What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?
Sustained abstinence is currently the only accepted end-point for pharmacotherapy trials for most substance use disorders (SUD), with the exception of alcohol. Despite recent efforts, the identification of a non-abstinence alternative as a clinically meaningful end-point for drug use trials has been...
Αποθηκεύτηκε σε:
| Κύριος συγγραφέας: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Journal Article |
| Γλώσσα: | Αγγλικά |
| Θέματα: | |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|
Παρόμοια τεκμήρια: What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?
- Cigarette smoke directly impairs skeletal muscle function through capillary regression and altered myofiber calcium kinetics in mice
- Brief school-based interventions and behavioural outcomes for substance-using adolescents (Review)
- Public health consequences of e-cigarettes
- Costs and unintended consequences of drug control policies
- The effectiveness of self-directed medical cannabis treatment for pain
- Usages de drogues en prision. Pratiques, conséquences et réponses